Fundraising Fox
/Companies
Sign in

iVeena Delivery Systems

Salt Lake City, US · Founded 2014 · Delaware corporation

Find your way into iVeena Delivery Systems

Sign up to see every warm intro you have to iVeena Delivery Systems

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the iVeena Delivery Systems team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

iVeena Delivery Systems is a clinical-stage ophthalmology company developing pharmacologic eye-drop therapies for refractive eye diseases, including IVMED-80 for keratoconus and IVMED-85 for pediatric myopia. Its lead keratoconus asset has been licensed to Glaukos Corporation.

BiotechHealthtechMedical Devices

Founders & leadership

iVeena Delivery Systems was founded in 2014 by Balamurali Ambati.

BABalamurali Ambati
Balamurali AmbatiFounder
GS
Gerald SimmonsExecutive
NWNed Weinshenker
Ned WeinshenkerExecutiveNed Weinshenker is a Ph.D. chemist who spent six decades in academic, industry, and government roles, including as CEO of multiple startups and an academic vice president, with substantial experience in pharmaceuticals, medical devices, and venture capital.

Board

DR
David RobinsonBoard director
JJ
James JensenBoard director
GJ
Greg JonesBoard director

Reported raises · per SEC filings

Form D private placements

$2.1M disclosed across 2 of 4 rounds · 2015–2019

▶$2.1MraisedJul 2020 · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Jayakrishna AmbatiDirector
  • Barry HanoverDirector
  • Ned WeinshenkerExecutive Officer, Director
  • Heffernan RonDirector
  • Robert DempseyDirector
  • Gerald SimmonsExecutive Officer, Director
  • Balamurali AmbatiExecutive Officer, Director
  • James U JensenDirector
Offering amount
$2.5M
Amount sold
$2.1M
Minimum investment
$10K
Proceeds to insiders
$200K
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$2.5MofferedDec 2017 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerald SimmonsExecutive Officer, Director
  • James U JensenDirector
  • Jayakrishna AmbatiDirector
  • Balamurali AmbatiExecutive Officer, Director
  • Ned WeinshenkerExecutive Officer, Director
  • Barry HanoverDirector
Offering amount
$2.5M
Minimum investment
$10K
Proceeds to insiders
$100K
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MofferedDec 2016 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David RobinsonDirector
  • Gerald SimmonsExecutive Officer, Director
  • Balamurali AmbatiExecutive Officer, Director
  • Ned WeinshenkerDirector
  • James JensenDirector
  • Jayakrishna AmbatiDirector
  • Barry HanoverDirector
Offering amount
$1M
Proceeds to insiders
$214K
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10KraisedMay 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerald SimmonsExecutive Officer
  • David RobinsonDirector
  • Ned WeinshenkerExecutive Officer, Director
  • James JensenDirector
  • Greg JonesDirector
  • Balamurali AmbatiExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$10K
Minimum investment
$10K
Proceeds to insiders
$100K
First sale
Apr 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
ZocdocZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.

Companies working in the same space as iVeena Delivery Systems.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$345K
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$2M
National Science FoundationPhase I2017$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$224.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2015$216.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia - BioSpacebiospace.com · Feb 2025

Frequently asked questions

What does iVeena Delivery Systems do?
iVeena Delivery Systems is a clinical-stage ophthalmology company developing pharmacologic eye-drop therapies for refractive eye diseases, including IVMED-80 for keratoconus and IVMED-85 for pediatric myopia. Its lead keratoconus asset has been licensed to Glaukos Corporation.
Who founded iVeena Delivery Systems?
iVeena Delivery Systems was founded by Balamurali Ambati in 2014.
How much funding has iVeena Delivery Systems raised?
iVeena Delivery Systems has disclosed $2.1M raised across 2 of its 4 known rounds.
Where is iVeena Delivery Systems headquartered?
iVeena Delivery Systems is headquartered in Salt Lake City, US.